TNF and inflammatory bowel disease: Five patients responded to induction therapy, and three of these patients had a sustained clinical response.73 In contrast, etanercept had no efficacy in the treatment of IBD.74 In fact, a Danish cohort study has demonstrated it is more likely than other anti-TNF agents to provoke de novo IBD when used for other autoimmune conditions.75